DR
Dipak Ramdas Nimase
About Dipak Ramdas Nimase
Data last updated:
Dipak Ramdas Nimase is a Director at Sandom Pharma Private Limited (since 2022) and Director at Menry Remidies Private Limited (since 2026). The companies operate in Chemicals. The largest current company by reported revenue is Sandom Pharma Private Limited at ₹8.5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sandom Pharma Private Limited U24239PN2022PTC210288 | Director | 12 Apr 2022 | 2022 | ₹8.5 Lakh (FY 2024) | Active |
| Menry Remidies Private Limited U46497MR2026PTC478040 | Director | 02 Jul 2026 | 2026 | Active |
Board colleagues of Dipak Ramdas Nimase
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanket Bhaskar Falke | 09569351 | Sandom Pharma Private Limited | Director |
| Devidas Rambhau Shinde | 11802978 | Menry Remidies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dipak Ramdas Nimase
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dipak Ramdas Nimase
Dipak Ramdas Nimase currently holds 2 directorships: Sandom Pharma Private Limited (Director, since 12 Apr 2022, revenue ₹8.5 Lakh (FY 2024)); Menry Remidies Private Limited (Director, since 02 Jul 2026).
Dipak Ramdas Nimase was first appointed on 12 Apr 2022 as Director at Sandom Pharma Private Limited. The most recent appointment on record is 02 Jul 2026 at Menry Remidies Private Limited.
The current boards of Dipak Ramdas Nimase's companies include Sanket Bhaskar Falke (Sandom Pharma Private Limited), Devidas Rambhau Shinde (Menry Remidies Private Limited).